Last reviewed · How we verify
NCT06874738
A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills
trial testing Liuwei Dihuang pills in Menopausal Syndrome in 1,000 participants. Not yet recruiting.
30 December 2026
Quick facts
| Lead sponsor | China Academy of Chinese Medical Sciences |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 8 March 2025 |
| Primary completion | 30 December 2026 |
| Estimated completion | 30 December 2026 |
Drugs / interventions tested
- Liuwei Dihuang pills — full drug profile →
Conditions studied
- Menopausal Syndrome — all drugs for Menopausal Syndrome →
Sponsor
China Academy of Chinese Medical Sciences — full company profile →
Who can join
Adults 45 to 55, female only, with Menopausal Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the clinical efficacy of the real-world Liuwei Dihuang pills for the treatment of female menopausal syndromes, and to provide a basis for effective, safe and rational clinical use of the drug.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Real-World Effectiveness and Safety of Liuwei Dihuang Pill for Menopausal Syndrome: Protocol for a Prospective, Observational, Multicenter Cohort Study.
Wei S, Zhang H, Wang M, Sun Y, et al · · 2026 · cited 1× · PMID 41879810 · DOI 10.2196/84803
Verify or expand the search:
- PubMed search for NCT06874738
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Menopausal Syndrome
Currently open trials in the same condition.
- NCT05280028 — HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness · recruiting
- NCT04031456 — Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients · Phase 2, PHASE3 · recruiting
Other China Academy of Chinese Medical Sciences trials
Trials by the same sponsor.
- NCT07319338 — Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis · not yet recruiting
- NCT05586048 — Effectiveness of Yiqi Fumai Lyophilized Injection for Acute Heart Failure · unknown
- NCT05138965 — the Method of Cotton Padding Promoting the Rectovaginal Fistula Surgery · completed
- NCT04932395 — Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis · Phase 4 · unknown
- NCT04714489 — Public Title：A Study on the Registration of The Use of Feilike HeJi in Adults · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06874738 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by China Academy of Chinese Medical Sciences
- Last refreshed: 13 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06874738.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing